Lv7
3490 积分 2022-05-31 加入
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
3天前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
3天前
已完结
Recent Advances in Peptide Linkers for Antibody-Drug Conjugates
5天前
已完结
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
14天前
已完结
Ovarian cancer
1个月前
已完结
Ovarian cancer
1个月前
已完结
Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of MTAP-Deleted Cancers
1个月前
已完结
Use of Human Dose Prediction Metrics to Enable Discovery of AZD3470, an MTA-Cooperative PRMT5 Inhibitor in Clinical Evaluation
1个月前
已完结
Medicinal chemistry strategies targeting PRMT5 for cancer therapy
1个月前
已完结
Drug discovery targeting protein arginine methyltransferase 5 (PRMT5): an update
1个月前
已完结
皖公网安备34019202002308
